Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activities
Growth Metrics
Income Statement
Others
Ratios

Acro Biomedical (ACBM) Change in Account Payables (2016 - 2021)

Acro Biomedical (ACBM) has 4 years of Change in Account Payables data on record, last reported at $10125.0 in Q4 2021.

  • For Q4 2021, Change in Account Payables fell 48.5% year-over-year to $10125.0; the TTM value through Dec 2021 reached $37787.0, up 45.88%, while the annual FY2022 figure was $50374.0, 3343.2% up from the prior year.
  • Change in Account Payables reached $10125.0 in Q4 2021 per ACBM's latest filing, up from $4000.0 in the prior quarter.
  • Across five years, Change in Account Payables topped out at $19662.0 in Q4 2020 and bottomed at -$5030.0 in Q1 2017.
  • Average Change in Account Payables over 3 years is $6551.4, with a median of $4000.0 recorded in 2020.
  • The widest YoY moves for Change in Account Payables: up 0.0% in 2021, down 48.5% in 2021.
  • A 3-year view of Change in Account Payables shows it stood at -$5030.0 in 2017, then skyrocketed by 490.89% to $19662.0 in 2020, then plummeted by 48.5% to $10125.0 in 2021.
  • Per Business Quant database, its latest 3 readings for Change in Account Payables were $10125.0 in Q4 2021, $4000.0 in Q3 2021, and $19662.0 in Q4 2020.